216 related articles for article (PubMed ID: 24331659)
1. A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases.
Brennan C; Yang TJ; Hilden P; Zhang Z; Chan K; Yamada Y; Chan TA; Lymberis SC; Narayana A; Tabar V; Gutin PH; Ballangrud Å; Lis E; Beal K
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):130-6. PubMed ID: 24331659
[TBL] [Abstract][Full Text] [Related]
2. Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection.
Bilger A; Bretzinger E; Fennell J; Nieder C; Lorenz H; Oehlke O; Grosu AL; Specht HM; Combs SE
Cancer Med; 2018 Jun; 7(6):2350-2359. PubMed ID: 29745035
[TBL] [Abstract][Full Text] [Related]
3. Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis.
Ahluwalia M; Barnett GH; Deng D; Tatter SB; Laxton AW; Mohammadi AM; Leuthardt E; Chamoun R; Judy K; Asher A; Essig M; Dietrich J; Chiang VL
J Neurosurg; 2018 May; 130(3):804-811. PubMed ID: 29726782
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant stereotactic radiosurgery for brain metastases: a new paradigm.
Li YD; Coxon AT; Huang J; Abraham CD; Dowling JL; Leuthardt EC; Dunn GP; Kim AH; Dacey RG; Zipfel GJ; Evans J; Filiput EA; Chicoine MR
Neurosurg Focus; 2022 Nov; 53(5):E8. PubMed ID: 36321291
[TBL] [Abstract][Full Text] [Related]
5. Postoperative Management of Recurrence After Radiosurgery and Surgical Resection for Brain Metastases and Predicting Benefit From Adjuvant Radiation.
Buszek SM; Tran B; Long JP; Luo D; Suki D; Li J; Ferguson S; Chung C
Pract Radiat Oncol; 2023; 13(6):e499-e503. PubMed ID: 37295724
[TBL] [Abstract][Full Text] [Related]
6. Reduced Mortality and Radiation Necrosis After Surgery With Postoperative Stereotactic Radiation in Patients With Multiple Brain Metastases.
Bhave VM; Lamba N; Tjong MC; Aizer AA; Bi WL
Neurosurgery; 2024 Jan; 94(1):117-128. PubMed ID: 37489905
[TBL] [Abstract][Full Text] [Related]
7. Response of treatment-naive brain metastases to stereotactic radiosurgery.
Ene CI; Abi Faraj C; Beckham TH; Weinberg JS; Andersen CR; Haider AS; Rao G; Ferguson SD; Alvarez-Brenkenridge CA; Kim BYS; Heimberger AB; McCutcheon IE; Prabhu SS; Wang CM; Ghia AJ; McGovern SL; Chung C; McAleer MF; Tom MC; Perni S; Swanson TA; Yeboa DN; Briere TM; Huse JT; Fuller GN; Lang FF; Li J; Suki D; Sawaya RE
Nat Commun; 2024 May; 15(1):3728. PubMed ID: 38697991
[TBL] [Abstract][Full Text] [Related]
8. Outcomes Following Early Postoperative Adjuvant Radiosurgery for Brain Metastases.
Bander ED; El Ahmadieh TY; Chen J; Reiner AS; Brown S; Giantini-Larsen AM; Young RJ; Beal K; Imber BS; Pike LRG; Brennan CW; Tabar V; Panageas KS; Moss NS
JAMA Netw Open; 2023 Oct; 6(10):e2340654. PubMed ID: 37906192
[TBL] [Abstract][Full Text] [Related]
9. Staged Stereotactic Radiosurgery for Large Brain Metastases: Local Control and Clinical Outcomes of a One-Two Punch Technique.
Dohm A; McTyre ER; Okoukoni C; Henson A; Cramer CK; LeCompte MC; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Watabe K; Laxton AW; Tatter SB; Chan MD
Neurosurgery; 2018 Jul; 83(1):114-121. PubMed ID: 28973432
[TBL] [Abstract][Full Text] [Related]
10. Surgery of enlarging lesions after stereotactic radiosurgery for brain metastases in patients with non-small cell lung cancer with oncogenic driver mutations frequently reveals radiation necrosis: case series and review.
Zhou F; Jiang L; Sun X; Wang Z; Feng J; Liu M; Ma Z
APMIS; 2024 Jun; 132(6):375-381. PubMed ID: 38466886
[TBL] [Abstract][Full Text] [Related]
11. Preoperative stereotactic radiosurgery before planned resection of brain metastases: updated analysis of efficacy and toxicity of a novel treatment paradigm.
Prabhu RS; Miller KR; Asher AL; Heinzerling JH; Moeller BJ; Lankford SP; McCammon RJ; Fasola CE; Patel KR; Press RH; Sumrall AL; Ward MC; Burri SH
J Neurosurg; 2018 Dec; 131(5):1387-1394. PubMed ID: 30554174
[TBL] [Abstract][Full Text] [Related]
12. Minimizing Intracranial Disease Before Stereotactic Radiation in Single or Solitary Brain Metastases.
Bhave VM; Lamba N; Aizer AA; Bi WL
Neurosurgery; 2023 Oct; 93(4):782-793. PubMed ID: 37036442
[TBL] [Abstract][Full Text] [Related]
13. Dose-Volume Tolerance of the Brain and Predictors of Radiation Necrosis After 3-Fraction Radiosurgery for Brain Metastases: A Large Single-Institutional Analysis.
Upadhyay R; Ayan AS; Jain S; Klamer BG; Perlow HK; Zoller W; Blakaj DM; Beyer S; Grecula J; Arnett A; Thomas E; Chakravarti A; Raval RR; Palmer JD
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):275-284. PubMed ID: 37574170
[TBL] [Abstract][Full Text] [Related]
14. Pre-operative vs. post-operative stereotactic radiosurgery for operative metastatic brain tumors: study protocol for a phase III clinical trial.
Routman DM; Jusue-Torres I; Brown PD; Trifiletti DM; Vora SA; Brown DA; Parney IF; Burns TC; Yan E
BMC Cancer; 2024 Mar; 24(1):332. PubMed ID: 38475765
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapy.
Hall J; Lui K; Tan X; Shumway J; Collichio F; Moschos S; Sengupta S; Chaudhary R; Quinsey C; Jaikumar S; Forbes J; Andaluz N; Zuccarello M; Struve T; Vatner R; Pater L; Breneman J; Weiner A; Wang K; Shen C
Radiother Oncol; 2023 Dec; 189():109920. PubMed ID: 37769968
[TBL] [Abstract][Full Text] [Related]
16. Preoperative stereotactic radiosurgery as neoadjuvant therapy for resectable brain tumors.
Crompton D; Koffler D; Fekrmandi F; Lehrer EJ; Sheehan JP; Trifiletti DM
J Neurooncol; 2023 Oct; 165(1):21-28. PubMed ID: 37889441
[TBL] [Abstract][Full Text] [Related]
17. Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of gastrointestinal origin.
Sandhu N; Benson KRK; Kumar KA; Eyben RV; Chang DT; Gibbs IC; Hancock SL; Meola A; Chang SD; Li G; Hayden-Gephart M; Soltys SG; Pollom EL
J Neurosurg Spine; 2020 Mar; 33(1):87-94. PubMed ID: 32114530
[TBL] [Abstract][Full Text] [Related]
18. Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases.
Juloori A; Miller JA; Parsai S; Kotecha R; Ahluwalia MS; Mohammadi AM; Murphy ES; Suh JH; Barnett GH; Yu JS; Vogelbaum MA; Rini B; Garcia J; Stevens GH; Angelov L; Chao ST
J Neurosurg; 2019 Jan; 132(1):188-196. PubMed ID: 30660120
[TBL] [Abstract][Full Text] [Related]
19. Delayed Imaging Changes 18 Months or Longer After Stereotactic Radiosurgery for Brain Metastases: Necrosis or Progression.
Williams MM; Sohrabi AK; Kittel CA; White JJ; Cramer CK; Lanier CM; Ruiz J; Xing F; Li W; Whitlow CT; Tatter SB; Chan MD; Laxton AW
World Neurosurg; 2024 Jan; 181():e453-e458. PubMed ID: 37865197
[TBL] [Abstract][Full Text] [Related]
20. Results of hypofractionated stereotactic radiotherapy for resected and intact large brain metastases.
Vetlova ER; Banov SM; Golanov AV; Pronin IN; Antipina NA; Galkin MV
Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(6):67-75. PubMed ID: 38054229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
